In a significant move aimed at enhancing patient safety and awareness, the Drugs Consultative Committee (DCC) under the Union health ministry has recommended amendments to the regulation mandating Quick Response (QR) codes for the top 300 drug brands. The proposed change includes comprehensive information on all excipients used in the drug formulation.